Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982) Research & Development: ¥109 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920982 Shanxi Jinbo Bio pharmaceutical Co Ltd BJSE:920982
78 GF Score
Price ¥129.49
GF Value ¥282.38
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Shanxi Jinbo Bio pharmaceutical Co Research & Development?

Shanxi Jinbo Bio pharmaceutical Co BJSE:920982 78 Research & Development is ¥109 Mil as of Mar. 2026. GuruFocus rates BJSE:920982 with a GF Score™ of 78/100 and a GF Value™ of ¥282.38 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Shanxi Jinbo Bio pharmaceutical Co's Research & Development for the three months ended in Mar. 2026 was ¥22 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥109 Mil.

Shanxi Jinbo Bio pharmaceutical Co  (BJSE:920982) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Shanxi Jinbo Bio pharmaceutical Co Research & Development Related Terms

Shanxi Jinbo Bio pharmaceutical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Shanxi Jinbo Bio pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanxi Jinbo Bio pharmaceutical Co Research & Development Chart

Shanxi Jinbo Bio pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.07 45.41 84.98 71.21 106.01

Shanxi Jinbo Bio pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.03 26.77 25.47 34.75 22.47
BJSE:920982
78GF Score
Shanxi Jinbo Bio pharmaceutical Co Ltd BJSE:920982
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanxi Jinbo Bio pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥109 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥109 Mil mean?
Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982) has a Research & Development of ¥109 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Shanxi Jinbo Bio pharmaceutical Co and its competitors.
Is Shanxi Jinbo Bio pharmaceutical Co's Research & Development too high?
Shanxi Jinbo Bio pharmaceutical Co's current Research & Development is ¥109 Mil. Overall, Shanxi Jinbo Bio pharmaceutical Co has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanxi Jinbo Bio pharmaceutical Co's Research & Development compare to VRTX and REGN?
Shanxi Jinbo Bio pharmaceutical Co's Research & Development of ¥109 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Shanxi Jinbo Bio pharmaceutical Co and its competitors. Shanxi Jinbo Bio pharmaceutical Co's current Research & Development is ¥109 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanxi Jinbo Bio pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥282.38, compared to a current price of ¥129.49 — trading 54.1% below its estimated fair value. The current Research & Development is ¥109 Mil. Shanxi Jinbo Bio pharmaceutical Co's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982), the current Research & Development is ¥109 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanxi Jinbo Bio pharmaceutical Co (BJSE:920982) Overvalued in 2026?

Based on GuruFocus' analysis, Shanxi Jinbo Bio pharmaceutical Co stock appears to be undervalued. The current stock price of ¥129.49 is trading 54.1% below its estimated GF Value™ of ¥282.38. GuruFocus considers Shanxi Jinbo Bio pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for BJSE:920982:

  • Research & Development: ¥109 Mil
  • GF Value™: ¥282.38 vs. price of ¥129.49 (54.1% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the BJSE:920982 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanxi Jinbo Bio pharmaceutical Co Business Description

Address No. 18, Jinbo Street, Tanghuai Park, Comprehensive Reform Demonstration Zone, Shanxi, Taiyuan, CHN, 030032
Shanxi Jinbo Bio pharmaceutical Co Ltd is engaged in research & development, production and sales of various medical devices and functional skin care products with recombinant collagen products and anti-HPV biological protein products as the core.
78GF Score

Get the complete analysis for BJSE:920982

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥129.49
Price
¥282.38
GF Value